Kevin Lobo
Director
Common Stock, par value $0.01 per share
- Reported value
- $641.8K
- Reported price
- $64.18 / share
GE HealthCare Technologies Inc.
Last 30 daysNo qualifying insider buying. No qualifying insider sales.
Showing the first 6 of 8 trades on this page.
Director
Common Stock, par value $0.01 per share
Director
Common Stock, par value $0.01 per share
Director
Common Stock, par value $0.01 per share
Director
Common Stock, par value $0.01 per share
Director
Common Stock, par value $0.01 per share
Chief Financial Officer
Common Stock, par value $0.01 per share
GC & Corporate Secretary
Common Stock, par value $0.01 per share
President and CEO
Common Stock, par value $0.01 per share
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Director | Common Stock, par value $0.01 per sharePurchase | 10,000$64.18 / share | $641.8K | May 22Filed May 26 · 4d later | SEC filing |
| Director | Common Stock, par value $0.01 per sharePurchase | 1,618$62.03 / share | $100.36K | May 12Filed May 13 · 1d later | SEC filing |
| Director | Common Stock, par value $0.01 per sharePurchase | 1,000$63.01 / share | $63.01K | May 8Filed May 11 · 3d later | SEC filing |
| Director | Common Stock, par value $0.01 per sharePurchase | 80,805$61.88 / share | $5M | May 6Filed May 7 · 1d later | SEC filing |
| Director | Common Stock, par value $0.01 per sharePurchase | 1,000$61.69 / share | $61.69K | May 6Filed May 7 · 1d later | SEC filing |
| Chief Financial Officer | Common Stock, par value $0.01 per sharePurchase | 3,310$60.60 / share | $200.59K | May 1Filed May 1 · 0d later | SEC filing |
| GC & Corporate Secretary | Common Stock, par value $0.01 per sharePurchase | 1,750$60.45 / share | $105.79K | Apr 30Filed Apr 30 · 0d later | SEC filing |
| President and CEO | Common Stock, par value $0.01 per sharePurchase | 4,169$59.93 / share | $249.83K | Apr 30Filed Apr 30 · 0d later | SEC filing |
$1,605,784 of common-equity purchase value after transaction-age decay across 180 days.
8 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.
Qualifying common-equity P acquisition; no disclosed plan, exercise or excluded purchase context detected.
Qualifying common-equity P acquisition; no disclosed plan, exercise or excluded purchase context detected.
At least one row increased reported same-security holdings by 10% or established a new reported position; indirect interests may overlap.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
GE HealthCare Technologies Inc. - Common Stock · Stock
The filing reports a purchase for the member.
GE HealthCare Technologies Inc. - Common Stock (GEHC) · Stock
The filing reports a sale for the member.
Terri A. SewellReporting House memberGE HealthCare Technologies Inc. - Common Stock (GEHC) · Stock
The filing reports a sale for the member.
Warren DavidsonReporting House member